The study evaluated aggregate, de-identified health data for 41,940 patients from HealthSnap’s RPM portals tailored by use case. It required inclusion criteria of at least 90 days on the program and a data transmission rate of at least 50%. The findings demonstrate significant improvements in clinical outcomes when RPM and CCM is administered as a comprehensive program for chronic condition management, including:
- Blood Pressure Improvements:
- Over 80% of hypertensive patients lowered their blood pressure compared to baseline.
- Patients with Stage 2 levels of systolic blood pressure (SBP) and diastolic blood pressure (DBP) saw the following reductions:
- SBP reduction of 23.8 mmHg
- DBP reduction of 14.5 mmHg
- Blood Glucose Control:
- Type II diabetic patients experienced a 16.5 mg/dL reduction in fasting blood glucose
- Severe hyperglycemic patients (≥180 mg/dL) had a 56.8mg/dL reduction
- Compared to the 40-60 mg/dL reduction seen with common non-insulin medications like Metformin and GLP-1 agonists
- Weight Loss:
- Among patients using Remote Patient Monitoring (RPM) for weight loss, 81.4% achieved long-term reductions in body weight